|
Q |
Colcr2 |
Colorectal carcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:2,266,368...22,711,984
|
|
Q |
Colcr5 |
Colorectal carcinoma resistance QTL 5 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:122,549,046...137,801,795
|
|
Q |
Colcr8 |
Colorectal carcinoma resistance QTL 8 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:22,066,242...52,293,055
|
|
Q |
Colcr9 |
Colorectal carcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr20:1,530,655...46,530,655
|
|
Q |
Eae2 |
Experimental allergic encephalomyelitis QTL 2 |
|
IDA |
|
RGD |
PMID:9973459 |
RGD:69694 |
NCBI chr 4:21,333,343...39,505,420
|
|
Q |
Eae3 |
Experimental allergic encephalomyelitis QTL 3 |
|
IDA |
|
RGD |
PMID:9973459 |
RGD:69694 |
NCBI chr10:26,521,957...61,345,413
|
|
Q |
Eau1 |
Experimental allergic uveoretinitis QTL 1 |
|
IDA |
|
RGD |
PMID:10323205 |
RGD:61073 |
NCBI chr 4:70,362,013...132,642,728
|
|
Q |
Eau2 |
Experimental allergic uveoretinitis QTL 2 |
|
IDA |
|
RGD |
PMID:10323205 |
RGD:61073 |
NCBI chr12:8,525,423...28,064,601
|
|
Q |
Eau3 |
Experimental allergic uveoretinitis QTL 3 |
|
IDA |
|
RGD |
PMID:10323205 |
RGD:61073 |
NCBI chr10:34,490,559...45,579,777
|
|
Q |
Eau4 |
Experimental allergic uveoretinitis QTL 4 |
|
IDA |
|
RGD |
PMID:18453595 |
RGD:2296064 |
NCBI chr 3:137,398,739...169,034,231
|
|
Q |
Eau5 |
Experimental allergic uveoretinitis QTL 5 |
|
IDA |
|
RGD |
PMID:18453595 |
RGD:2296064 |
NCBI chr 2:202,446,871...237,938,339
|
|
Q |
Eau6 |
Experimental allergic uveoretinitis QTL 6 |
|
IDA |
|
RGD |
PMID:18453595 |
RGD:2296064 |
NCBI chr 7:84,257,275...129,257,275
|
|
Q |
Eau7 |
Experimental allergic uveoretinitis QTL 7 |
|
IDA |
|
RGD |
PMID:18453595 |
RGD:2296064 |
NCBI chr10:27,957,626...34,490,668
|
|
Q |
Eau8 |
Experimental allergic uveoretinitis QTL 8 |
|
IDA |
|
RGD |
PMID:18453595 |
RGD:2296064 |
NCBI chr19:17,154,433...57,337,602
|
|
Q |
Eau9 |
Experimental allergic uveoretinitis QTL 9 |
|
IDA |
|
RGD |
PMID:18453595 |
RGD:2296064 |
NCBI chr10:65,927,233...82,565,079
|
|
Q |
Edcs1 |
Endometrial carcinoma susceptibility QTL1 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr11:18,976,208...24,697,116
|
|
Q |
Edcs2 |
Endometrial carcinoma susceptibility QTL2 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr12:6,833,190...17,870,186
|
|
Q |
Edcs3 |
Endometrial carcinoma susceptibility QTL3 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr20:1...25,159,026
|
|
Q |
Edcs4 |
Endometrial carcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr 1:206,081,677...251,081,677
|
|
Q |
Edcs5 |
Endometrial carcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11745480 |
RGD:1599856 |
NCBI chr17:57,246,723...70,852,846
|
|
Q |
Gdil1 |
Gastrointestinal dilation QTL 1 |
|
IDA |
|
RGD |
PMID:21915282 |
RGD:6480217 |
NCBI chr 2:56,660,879...74,786,777
|
|
Q |
Glom1 |
Glomerulus QTL 1 |
|
IDA |
|
RGD |
PMID:12397040 |
RGD:634618 |
NCBI chr X:75,294,106...120,294,106
|
|
Q |
Glom15 |
Glomerulus QTL 15 |
|
IDA |
|
RGD |
PMID:16482158 |
RGD:2293335 |
NCBI chr13:74,862,117...101,339,893
|
|
Q |
Glom16 |
Glomerulus QTL 16 |
|
IDA |
|
RGD |
PMID:16482158 |
RGD:2293335 |
NCBI chr16:832,236...46,053,497
|
|
Q |
Glom2 |
Glomerulus QTL 2 |
|
IDA |
|
RGD |
PMID:12397040 |
RGD:634618 |
NCBI chr 1:222,363,780...260,522,016
|
|
Q |
Glom24 |
Glomerulus QTL 24 |
|
IDA |
|
RGD |
PMID:16482158 |
RGD:2293335 |
NCBI chr 5:97,570,330...136,479,578
|
|
Q |
Glom27 |
Glomerulus QTL 27 |
|
IDA |
|
RGD |
PMID:22445570 |
RGD:7207870 |
NCBI chr13:20,605,871...101,339,738
|
|
Q |
Glom3 |
Glomerulus QTL 3 |
|
IDA |
|
RGD |
PMID:12397040 |
RGD:634618 |
|
|
Q |
Glom4 |
Glomerulus QTL 4 |
|
IDA |
|
RGD |
PMID:14638907 |
RGD:730279 |
NCBI chr 2:20,304,672...65,304,672
|
|
Q |
Glom5 |
Glomerulus QTL 5 |
|
IDA |
|
RGD |
PMID:14638907 |
RGD:730279 |
NCBI chr 7:96,670,164...135,012,528
|
|
Q |
Glom6 |
Glomerulus QTL 6 |
|
IDA |
|
RGD |
PMID:14638907 |
RGD:730279 |
NCBI chr 9:64,573,531...109,573,531
|
|
Q |
Glom7 |
Glomerulus QTL 7 |
|
IDA |
|
RGD |
PMID:14638907 |
RGD:730279 |
NCBI chr 6:71,201,409...116,201,409
|
|
Q |
Glom8 |
Glomerulus QTL 8 |
|
IDA |
|
RGD |
PMID:14638907 |
RGD:730279 |
NCBI chr 6:86,894,788...131,894,788
|
|
Q |
Iddm24 |
Insulin dependent diabetes mellitus QTL 24 |
|
IDA |
|
RGD |
PMID:17389329 |
RGD:1624306 |
NCBI chr 8:112,834,440...118,649,220
|
|
Q |
Kiddil1 |
Kidney dilation QTL 1 |
|
IDA |
|
RGD |
PMID:18523158 |
RGD:2293631 |
NCBI chr 6:81,132,889...104,393,926
|
|
Q |
Kiddil2 |
Kidney dilation QTL 2 |
|
IDA |
|
RGD |
PMID:18523158 |
RGD:2293631 |
NCBI chr 6:20,866,422...81,133,036
|
|
Q |
Kiddil3 |
Kidney dilation QTL 3 |
|
IDA |
|
RGD |
PMID:18523158 |
RGD:2293631 |
NCBI chr 6:81,132,889...104,393,926
|
|
Q |
Kiddil4 |
Kidney dilation QTL 4 |
|
IDA |
|
RGD |
PMID:18523158 |
RGD:2293631 |
NCBI chr 6:20,866,422...81,133,036
|
|
Q |
Kiddil5 |
Kidney dilation QTL 5 |
|
IDA |
|
RGD |
PMID:18523158 |
RGD:2293631 |
NCBI chr 2:42,804,607...157,142,209
|
|
Q |
Kiddil6 |
Kidney dilation QTL 6 |
|
IDA |
|
RGD |
PMID:18523158 |
RGD:2293631 |
NCBI chr 2:42,804,607...182,042,367
|
|
Q |
Kiddil7 |
Kidney dilation QTL 7 |
|
IDA |
|
RGD |
PMID:18523158 |
RGD:2293631 |
NCBI chr 2:219,753,301...247,136,170
|
|
Q |
Kiddil8 |
Kidney dilation QTL 8 |
|
IDA |
|
RGD |
PMID:18523158 |
RGD:2293631 |
NCBI chr 2:219,753,301...247,136,170
|
|
Q |
Kiddil9 |
Kidney dilation QTL 9 |
|
IDA |
|
RGD |
PMID:18523158 |
RGD:2293631 |
NCBI chr 4:120,926,564...148,090,731
|
|
Q |
Mcs2 |
Mammary carcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 7:19,032,807...35,526,300
|
|
Q |
Mcsm1 |
Mammary carcinoma susceptibility modifier QTL 1 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 6:58,632,962...103,632,962
|
|
Q |
Panci1 |
Pancreas inflammation QTL 1 |
|
IDA |
|
RGD |
PMID:11414764 |
RGD:619682 |
NCBI chr 7:116,677,189...127,103,496
|
|
Q |
Pancm1 |
Pancreatic morphology QTL 1 |
|
IDA |
|
RGD |
PMID:9169130 |
RGD:61083 |
NCBI chr 1:181,759,564...214,537,555
|
|
Q |
Plsm1 |
Polydactyly-luxate syndrome (PLS) morphotypes QTL 1 |
|
IDA |
|
RGD |
PMID:8997636 |
RGD:632346 |
NCBI chr 4:1...27,716,890
|
|
Q |
Plsm2 |
Polydactyly-luxate syndrome (PLS) morphotypes QTL 2 |
|
IDA |
|
RGD |
PMID:8997636 |
RGD:632346 |
NCBI chr 4:132,422,778...177,422,778
|
|
Q |
Plsm4 |
Polydactyly-luxate syndrome (PLS) morphotypes QTL 4 |
|
IDA |
|
RGD |
PMID:8997636 |
RGD:632346 |
NCBI chr11:54,457,534...86,241,447
|
|
Q |
Prcs1 |
Prostate cancer susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr19:15,114,598...34,521,833
|
|
Q |
Prcs2 |
Prostate cancer susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr20:4,606,607...17,617,956
|
|
Q |
Rends1 |
Renal damage susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10454439 |
RGD:632218 |
NCBI chr 1:169,537,671...214,537,671
|
|
Q |
Rends2 |
Renal damage susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:12874092 |
RGD:631854 |
NCBI chr 1:19,333,571...56,983,283
|
|
Q |
Rends3 |
Renal damage susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:12874092 |
RGD:631854 |
NCBI chr10:79,813,789...85,160,854
|
|
Q |
Rends4 |
Renal damage susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:12874092 |
RGD:631854 |
NCBI chr16:1...26,727,669
|
|
Q |
Rf20 |
Renal function QTL 20 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr11:29,528,418...60,324,829
|
|
Q |
Rf9 |
Renal function QTL 9 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 2:133,914,684...202,447,032
|
|
Q |
Strs1 |
Sensitivity to stroke QTL 1 |
|
IDA |
|
RGD |
PMID:8696337 |
RGD:61093 |
NCBI chr 1:121,767,634...166,767,634
|
|
Q |
Strs2 |
Sensitivity to stroke QTL 2 |
|
IDA |
|
RGD |
PMID:8696337 |
RGD:61093 |
NCBI chr 5:135,929,696...166,875,058
|
|
Q |
Strs3 |
Sensitivity to stroke QTL 3 |
|
IDA |
|
RGD |
PMID:8696337 |
RGD:61093 |
NCBI chr 4:40,433,388...85,433,388
|
|
Q |
Tescar1 |
Testicular tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr11:1,041,931...66,113,562
|
|
Q |
Toxo1 |
Toxoplasma gondii resistance QTL 1 |
|
IDA |
|
RGD |
PMID:16407112 |
RGD:1578521 |
NCBI chr10:52,200,030...59,378,278
|
|
Q |
Vetf10 |
Vascular elastic tissue fragility QTL 10 |
|
IDA |
|
RGD |
PMID:17356016 |
RGD:8662443 |
NCBI chr10:6,154,182...73,453,136
|
|
Q |
Vetf3 |
Vascular elastic tissue fragility QTL 3 |
|
IDA |
|
RGD |
PMID:17356016 |
RGD:8662443 |
NCBI chr 5:2,282,226...69,540,447
|
|
Q |
Vetf4 |
Vascular elastic tissue fragility QTL 4 |
|
IDA |
|
RGD |
PMID:17356016 |
RGD:8662443 |
NCBI chr 3:59,242,096...157,323,038
|
|
Q |
Vetf5 |
Vascular elastic tissue fragility QTL 5 |
|
IDA |
|
RGD |
PMID:17356016 |
RGD:8662443 |
NCBI chr 8:28,242,912...99,525,068
|
|
Q |
Vetf6 |
Vascular elastic tissue fragility QTL 6 |
|
IDA |
|
RGD |
PMID:17356016 |
RGD:8662443 |
NCBI chr 9:36,962,359...92,058,970
|
|
Q |
Wbc1 |
White blood cell count QTL 1 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 5:125,392,826...139,989,768
|
|
|
Q |
Bp49 |
Blood pressure QTL 49 |
|
IDA |
|
RGD |
PMID:9241273 |
RGD:61056 |
NCBI chr 5:60,293,434...98,603,051
|
|
Q |
Bw61 |
Body weight QTL61 |
|
IDA |
|
RGD |
PMID:11853145 |
RGD:619672 |
NCBI chr 1:173,108,781...218,108,781
|
|
Q |
Glom10 |
Glomerulus QTL 10 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
NCBI chr11:1...35,331,169
|
|
Q |
Glom11 |
Glomerulus QTL 11 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
|
|
Q |
Glom12 |
Glomerulus QTL 12 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
NCBI chr 5:33,215,665...78,215,665
|
|
Q |
Glom13 |
Glomerulus QTL 13 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
|
|
Q |
Glom14 |
Glomerulus QTL 14 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
NCBI chr15:34,054,139...79,054,139
|
|
Q |
Glom17 |
Glomerulus QTL 17 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
NCBI chr 1:166,532,971...191,278,129
|
|
Q |
Glom18 |
Glomerulus QTL 18 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
NCBI chr 1:185,356,336...231,689,108
|
|
Q |
Glom19 |
Glomerulus QTL 19 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
NCBI chr 4:45,456,990...146,803,430
|
|
Q |
Glom20 |
Glomerulus QTL 20 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
NCBI chr11:44,285,759...82,566,702
|
|
Q |
Glom21 |
Glomerulus QTL 21 |
|
IDA |
|
RGD |
PMID:18682577 |
RGD:2312422 |
NCBI chr18:5,185,858...40,503,530
|
|
Q |
Glom9 |
Glomerulus QTL 9 |
|
IDA |
|
RGD |
PMID:16720678 |
RGD:1581737 |
NCBI chr 2:92,337,601...137,337,601
|
|
Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr10:6,154,182...15,990,232
|
|
Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 8:40,713,066...82,925,667
|
|
Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 6:82,523,650...110,548,006
|
|
Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 3:29,463,235...118,376,539
|
|
Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 4:1...32,584,199
|
|
Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr18:51,464,733...83,218,561
|
|
Q |
Hcar15 |
Hepatocarcinoma resistance QTL 15 |
|
IDA |
|
RGD |
PMID:15771619 |
RGD:1358145 |
NCBI chr 1:153,136,852...260,522,016
|
|
Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 4:78,878,504...123,878,504
|
|
Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 8:54,237,644...99,103,503
|
|
Q |
Hcar4 |
Hepatocarcinoma resistance QTL 4 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:193,422,268...214,537,671
|
|
Q |
Hcar5 |
Hepatocarcinoma resistance QTL 5 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:214,537,555...226,660,468
|
|
Q |
Hcar6 |
Hepatocarcinoma resistance QTL 6 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
|
|
Q |
Hcar7 |
Hepatocarcinoma resistance QTL 7 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:70,808,386...115,808,386
|
|
Q |
Hcar8 |
Hepatocarcinoma resistance QTL 8 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:123,143,783...168,143,783
|
|
Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 4:109,866,907...167,139,601
|
|
Q |
Hcas1 |
Hepatocarcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 7:91,412,594...129,807,172
|
|
Q |
Hcas2 |
Hepatocarcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 1:5,925,874...115,540,829
|
|
Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 1:144,267,353...222,987,745
|
|
Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr16:4,227,609...46,975,965
|
|
Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 1:176,426,412...257,976,495
|
|
Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr14:39,057,237...83,368,335
|
|
Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr15:2,266,368...46,921,453
|
|
Q |
Hcas8 |
Hepatocarcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:17079458 |
RGD:1599590 |
NCBI chr16:1...22,477,621
|
|
Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 2:1...41,244,106
|
|
Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:1...42,356,786
|
|
Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:59,874,408...85,581,182
|
|
Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:74,862,117...85,581,182
|
|
Q |
Pancm2 |
Pancreatic morphology QTL 2 |
|
IDA |
|
RGD |
PMID:20878524 |
RGD:4889455 |
NCBI chr10:76,748,906...107,211,142
|
|
Q |
Prcr1 |
Prostate cancer resistance QTL 1 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 2:72,532,993...157,142,209
|
|
Q |
Prcr2 |
Prostate cancer resistance QTL 2 |
|
IDA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 1:20,763,158...44,095,856
|
|
Q |
Rf57 |
Renal function QTL 57 |
|
IDA |
|
RGD |
PMID:19584172 |
RGD:2316856 |
NCBI chr 5:59,793,528...90,450,144
|
|
Q |
Rf58 |
Renal function QTL 58 |
|
IDA |
|
RGD |
PMID:19584172 |
RGD:2316856 |
NCBI chr 7:68,938,720...113,886,318
|
|
Q |
Smcn1 |
Smooth muscle cell number QTL 1 |
|
IDA |
|
RGD |
PMID:15741507 |
RGD:1357419 |
NCBI chr 2:59,134,147...127,460,910
|
|
Q |
Vnigr1 |
Vascular neointimal growth QTL 1 |
|
IDA |
|
RGD |
PMID:16434542 |
RGD:1578306 |
NCBI chr 3:149,040,888...168,026,850
|
|
Q |
Vnigr2 |
Vascular neointimal growth QTL 2 |
|
IDA |
|
RGD |
PMID:16434542 |
RGD:1578306 |
NCBI chr 3:130,656,562...169,034,231
|
|
Q |
Vnigr3 |
Vascular neointimal growth QTL 3 |
|
IDA |
|
RGD |
PMID:16434542 |
RGD:1578306 |
NCBI chr 3:130,656,562...169,034,231
|
|
|
Q |
Gdil2 |
Gastrointestinal dilation QTL 2 |
|
IDA |
|
RGD |
PMID:25790447 |
RGD:10402048 |
NCBI chr 2:24,903,853...74,786,777
|
|
|
Q |
Gcr3 |
Gastric cancer resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,696,791...82,635,055
|
|
Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 7:34,293,282...79,293,282
|
|
Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 1:233,948,574...260,522,016
|
|
Q |
Neuinf4 |
Neuroinflammation QTL 4 |
|
IDA |
|
RGD |
PMID:19525015 |
RGD:2311085 |
NCBI chr 1:1...28,736,750
|
|
Q |
Neuinf5 |
Neuroinflammation QTL 5 |
|
IDA |
|
RGD |
PMID:19525015 |
RGD:2311085 |
NCBI chr 7:9,462,246...58,265,113
|
|
Q |
Neuinf6 |
Neuroinflammation QTL 6 |
|
IDA |
|
RGD |
PMID:19525015 |
RGD:2311085 |
NCBI chr 7:1...27,829,089
|
|
Q |
Neuinf7 |
Neuroinflammation QTL 7 |
|
IDA |
|
RGD |
PMID:19525015 |
RGD:2311085 |
NCBI chr10:72,224,939...107,211,142
|
|
|
Q |
Tspe1 |
Trichinella spiralis expulsion QTL 1 |
|
IDA |
|
RGD |
PMID:16465509 |
RGD:1578305 |
NCBI chr 9:61,381,434...65,691,299
|
|